The agreements are expected to expand the application of Codexis’ technology to a broadened pipeline of branded innovator pharmaceutical products. As per the new agreements, Codexis will apply
Roche’s investigational AmpliChip p53 Test is designed to detect damage to p53 DNA in tumor cells in order to identify which cells carry dysfunctional p53 proteins that can
Roche’s investigational AmpliChip p53 Test is designed to detect damage to p53 DNA in tumor cells in order to identify which cells carry dysfunctional p53 proteins that can
Sanofi-aventis said that the aim of the research partnership with Aviesan is to enhance scientific knowledge in the areas of life sciences and healthcare, to develop projects benefiting
Both the companies are evaluating the complete response letter, in which the FDA has indicated that a preclinical finding of pancreatic acinar cell tumors in rats was of
To support a whole product solution with the commercial launch of the SMRT system in the second half of 2010, Pacific Biosciences has developed a formal partner program
The alliance aims to discover and develop antibody therapeutics based on novel modes of action in bone and joint diseases, including rheumatoid arthritis, osteoporosis and osteoarthritis. As part
As per the amended agreement, Biogen Idec is expected to assume full development responsibilities and costs, as well as manufacturing rights for the rFVIIIFc and rFIXFc programs. Biogen
The funding will be directed towards the first phase of a two year translational programme to take human retinal progenitor cells (hRPCs) towards the clinic in the US,
ATHENA is a prospective, double-blind, multi-centered, 47,000-patient, US-registration trial designed to demonstrate the effectiveness of HPV detection as part of a cervical cancer screening program. The Roche ATHENA
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.